A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis

NCT04898348 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No patients recruited

Conditions

Ulcerative Colitis

Interventions

DRUG: KBL697
DRUG: Placebo

Sponsor

KoBioLabs